Company · CIK 0000882095 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
GILEAD SCIENCES, INC. · GILD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 FMForm 4 → | Sep 23, 4:17 pm EDT | Erin BurkhartSVP, Controllership | 2,991 | $152.67 | $117,251 | 1,455 | — | |
| Sep 15, 2026 SForm 4 → | Sep 16, 4:30 pm EDT | Andrew D DickinsonChief Financial Officer | 3,000 | $145.29 | $435,870 | 164,096 | −1.80% | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 16, 4:27 pm EDT | Johanna MercierChief Comm & Corp Aff Officer | 3,000 | $144.22 | $432,646 | 116,684 | −2.51% | 10b5-1 |
| Sep 10, 2026 FMForm 4 → | Sep 11, 6:30 pm EDT | Andrew D DickinsonChief Financial Officer | 4,144 | $144.81 | $195,059 | 167,096 | — | |
| Sep 10, 2026 FMForm 4 → | Sep 11, 6:29 pm EDT | Dietmar BergerChief Medical Officer | 796 | $144.81 | $38,085 | 19,522 | — | |
| Sep 10, 2026 FMForm 4 → | Sep 11, 6:28 pm EDT | Johanna MercierChief Comm & Corp Aff Officer | 4,144 | $144.81 | $195,059 | 119,684 | — | |
| Sep 10, 2026 FMForm 4 → | Sep 11, 6:28 pm EDT | Wettan Keeley M CainEVP Gen Counsel, Legal & Comp | 875 | $144.81 | $41,271 | 8,759 | — | |
| Sep 10, 2026 FMForm 4 → | Sep 11, 6:27 pm EDT | Daniel Patrick O'DayChairman & CEO, Director | 13,010 | $144.81 | $612,546 | 581,683 | — | |
| Sep 1, 2026 SForm 4 → | Sep 2, 4:12 pm EDT | Daniel Patrick O'DayChairman & CEO, Director | 15,000 | $148.64 | $2,229,592 | 577,133 | −2.53% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 MForm 4 → | Sep 23, 4:17 pm EDT | Erin BurkhartSVP, Controllership | 2,223 | — | — | 9,022 | — | |
| Sep 10, 2026 MForm 4 → | Sep 11, 6:30 pm EDT | Andrew D DickinsonChief Financial Officer | 2,797 | — | — | 25,054 | — | |
| Sep 10, 2026 MForm 4 → | Sep 11, 6:29 pm EDT | Dietmar BergerChief Medical Officer | 533 | — | — | 46,395 | — | |
| Sep 10, 2026 MForm 4 → | Sep 11, 6:28 pm EDT | Johanna MercierChief Comm & Corp Aff Officer | 2,797 | — | — | 25,054 | — | |
| Sep 10, 2026 MForm 4 → | Sep 11, 6:28 pm EDT | Wettan Keeley M CainEVP Gen Counsel, Legal & Comp | 590 | — | — | 13,405 | — | |
| Sep 10, 2026 MForm 4 → | Sep 11, 6:27 pm EDT | Daniel Patrick O'DayChairman & CEO, Director | 8,780 | — | — | 83,300 | — |